BeStock  
Stocks › Biotechnology › JANX

Janux Therapeutics JANX

US equityMarket cap rank #3178Biotechnology
$17.92 +$1.13 (+6.73%)
Pre-market · Oct 8, 8:20 am ET · After hours $18.50 +3.24%
Open$16.52
Prev close$16.79
Day range$16.42 – $18.37
Volume1.21M
Market cap$1.10B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts11
Average target$34.22+91.0% vs. price
  • Buy 91%
  • Sell 9%
Low $14.00Now $17.92Avg $34.22High $60.00

Recent rating changes

The last 20 actions on file set price targets from $14.00 to $60.00, averaging $37.56.

DateFirmRatingTarget
1 Oct 2026 H.C. Wainwright BUY $45.00
24 Aug 2026 Wolfe Research BUY $23.00
13 Aug 2026 William Blair BUY –
11 Aug 2026 Stifel BUY $35.00
10 Aug 2026 H.C. Wainwright BUY $45.00
7 Aug 2026 LifeSci Capital BUY $60.00
7 Aug 2026 William Blair BUY –
7 Aug 2026 JonesTrading BUY $28.00
7 Aug 2026 Piper Sandler BUY $26.00
7 Aug 2026 BofA Securities BUY $22.00
7 Aug 2026 Truist Financial BUY –
7 Aug 2026 Stifel BUY $35.00
7 Aug 2026 Barclays SELL $14.00
6 Aug 2026 Guggenheim BUY $55.00
25 Jun 2026 Truist Financial BUY $26.00
11 May 2026 Evercore BUY $22.00
11 May 2026 H.C. Wainwright BUY $45.00
9 May 2026 LifeSci Capital BUY $60.00
8 May 2026 TD Cowen BUY –
8 May 2026 LifeSci Capital BUY $60.00

Discussion

No comments yet — be the first to weigh in on JANX.

Leave a comment

Scroll to Top